FDG-PET
FDG-PET is an intervention with 31 clinical trials. Currently 7 active trials ongoing. Historical success rate of 77.8%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
70.0%
14 of 20 finished
30.0%
6 ended early
7
trials recruiting
31
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
FDG-PET in the Diagnosis of Autoimmune Encephalitis
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
Somatostatin Receptor Imaging in NPC, EBV Related Cancers
Cognitive Function and Fatigue After Brain Abscess
Cerebral Atherosclerosis Research With Positron Emission Tomography
Clinical Trials (31)
FDG-PET in the Diagnosis of Autoimmune Encephalitis
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
Somatostatin Receptor Imaging in NPC, EBV Related Cancers
Cognitive Function and Fatigue After Brain Abscess
Cerebral Atherosclerosis Research With Positron Emission Tomography
Treatment and Natural History Study of Lymphomatoid Granulomatosis
Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma
Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories
Alterations in the Brain's Connectome After Severe Traumatic Brain Injury
Glucocorticoid Long-term Administration: Effect on Cold Induced Energy Expenditure and Resting Metabolic Rate
Arterial Spin Labeling (ASL) MRI for Cognitive Decline
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 31